Trevi Therapeutics, Inc.
TRVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563880
In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q1 2025
Institutional positions in Trevi Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 137
- +28 vs. Q4 2024
- Shares held
- 88.1M
- +8.73M (+11.0%) vs. Q4 2024
- Total value
- $554.3M
- +$225.2M (+68.4%) vs. Q4 2024
- New holders
- 42
- 53 more added
- Sold out
- 14
- 32 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 218 | $2.76B |
| Q1 2026 | 198 | $1.61B |
| Q4 2025 | 184 | $1.63B |
| Q3 2025 | 164 | $1.18B |
| Q2 2025 | 154 | $627.2M |
| Q1 2025 | 137 | $554.3M |
| Q4 2024 | 110 | $329.5M |
| Q3 2024 | 93 | $194.1M |
| Q2 2024 | 77 | $166.6M |
| Q1 2024 | 80 | $177.9M |
| Q4 2023 | 63 | $70.0M |
| Q3 2023 | 55 | $106.1M |
| Q2 2023 | 53 | $116.7M |
| Q1 2023 | 36 | $80.4M |
| Q4 2022 | 37 | $83.3M |
| Q3 2022 | 40 | $70.5M |
| Q2 2022 | 32 | $80.8M |
| Q1 2022 | 23 | $32.9M |
| Q4 2021 | 17 | $10.3M |
| Q3 2021 | 18 | $17.4M |
| Q2 2021 | 17 | $28.1M |
| Q1 2021 | 19 | $35.6M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Trevi Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 340,164 | $2.14M | 0.09% | +340,164 | New |
| Logos Global Management LP | 424,715 | $2.67M | 0.47% | −825,285−66.0% | Reduced |
| Adage Capital Partners GP, L.L.C. | 440,000 | $2.77M | 0.01% | −2,060,000−82.4% | Reduced |
| Morgan Stanley | 494,567 | $3.11M | 0.00% | +303,698+159.1% | Added |
| Raymond James Financial Inc | 509,379 | $3.20M | 0.00% | +497,379+4,144.8% | Added |
| Silverarc Capital Management, LLC | 530,000 | $3.33M | 0.70% | −204,234−27.8% | Reduced |
| EAM Investors, LLC | 550,919 | $3.47M | 0.60% | +550,919 | New |
| Northern Trust Corp | 566,197 | $3.56M | 0.00% | +83,382+17.3% | Added |
| Ikarian Capital, LLC | 575,000 | $3.62M | 1.18% | +250,000+76.9% | Added |
| Rosalind Advisors, Inc. | 612,901 | $3.86M | 1.88% | −449,599−42.3% | Reduced |
| VR Adviser, LLC | 615,506 | $3.87M | 0.33% | −650,951−51.4% | Reduced |
| Ally Bridge Group (NY) LLC | 686,219 | $4.32M | 3.89% | −95,270−12.2% | Reduced |
| Acuta Capital Partners, LLC | 785,961 | $4.94M | 5.73% | +14,003+1.8% | Added |
| Opaleye Management Inc. | 795,000 | $5.00M | 1.11% | −1,522,500−65.7% | Reduced |
| Millennium Management LLC | 823,249 | $5.18M | 0.01% | +642,830+356.3% | Added |
| Invesco Ltd. | 852,985 | $5.37M | 0.00% | +829,364+3,511.1% | Added |
| OrbiMed Advisors LLC | 1,120,000 | $7.04M | 0.17% | +1,120,000 | New |
| Affinity Asset Advisors, LLC | 1,250,000 | $7.86M | 1.23% | +1,250,000 | New |
| MAI Capital Management | 1,385,050 | $8.71M | 0.07% | +28,164+2.1% | Added |
| State Street Corp | 1,424,506 | $8.96M | 0.00% | +253,824+21.7% | Added |
| Geode Capital Management, LLC | 1,614,865 | $10.2M | 0.00% | +315,543+24.3% | Added |
| Balyasny Asset Management LLC | 1,758,619 | $11.1M | 0.03% | +1,758,619 | New |
| Woodline Partners LP | 2,057,812 | $12.9M | 0.08% | −1,154,785−35.9% | Reduced |
| Acorn Capital Advisors, LLC | 2,144,844 | $13.5M | 9.00% | +143,796+7.2% | Added |
| Point72 Asset Management, L.P. | 2,368,005 | $14.9M | 0.04% | −1,782,232−42.9% | Reduced |
| Marshall Wace, LLP | 2,554,221 | $16.1M | 0.02% | +2,511,300+5,851.0% | Added |
| Siren, L.L.C. | 2,863,793 | $18.0M | 1.02% | −42,267−1.5% | Reduced |
| Armistice Capital, LLC | 2,988,000 | $18.8M | 0.50% | +2,988,000 | New |
| Viking Global Investors LPSuperinvestorViking Global Investors | 3,227,792 | $20.3M | 0.06% | −1,172,208−26.6% | Reduced |
| Octagon Capital Advisors LP | 3,322,000 | $20.9M | 4.54% | +3,322,000 | New |
| MPM Oncology Impact Management LP | 3,428,366 | $21.6M | 3.71% | +333,470+10.8% | Added |
| Vivo Capital, LLC | 3,487,903 | $21.9M | 2.91% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,838,032 | $24.1M | 0.00% | +328,819+9.4% | Added |
| Rubric Capital Management LP | 4,538,535 | $28.5M | 0.51% | +333,406+7.9% | Added |
| BlackRock, Inc. | 5,312,542 | $33.4M | 0.00% | +1,384,080+35.2% | Added |
| Frazier Life Sciences Management, L.P. | 10,259,409 | $64.5M | 2.95% | −405,365−3.8% | Reduced |
| NEA Management Company, LLC | 11,370,376 | $71.5M | 5.51% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,233,176−100.0% | Sold out |
| Checkpoint Capital L.P. | 0 | $0 | 0.00% | −1,084,135−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −120,212−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −52,085−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −36,000−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −33,097−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −24,913−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −21,255−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −14,779−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −10,048−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −2,320−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −68−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |